2021
DOI: 10.1007/s10557-021-07179-x
|View full text |Cite
|
Sign up to set email alerts
|

What Is the Role of Assessing Ischemia to Optimize Therapy and Outcomes for Patients with Stable Angina and Non-obstructed Coronary Arteries?

Abstract: Ischemic heart disease (IHD) is a leading global cause of ill-health and premature death. Clinical research into IHD is providing new insights into the pathophysiology, epidemiology and treatment of this condition. The major endotypes of IHD include coronary heart disease (CHD) and vasomotor disorders, including microvascular angina and vasospastic angina. Considering unselected patients presenting with stable chest pain, the pre-test probability of CHD is higher in men whereas the pre-test probability of a va… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 77 publications
0
3
0
Order By: Relevance
“…MPS is the most specific of the non-invasive options for myocardial ischemia [ 45 ]. However, in women, accuracy is lower due to smaller heart size and higher left ventricular ejection fraction, and is less frequently the first investigation of choice in women due to increased radiation exposure [ 46 ].…”
Section: Diagnosing Ischemic Heart Disease In Womenmentioning
confidence: 99%
“…MPS is the most specific of the non-invasive options for myocardial ischemia [ 45 ]. However, in women, accuracy is lower due to smaller heart size and higher left ventricular ejection fraction, and is less frequently the first investigation of choice in women due to increased radiation exposure [ 46 ].…”
Section: Diagnosing Ischemic Heart Disease In Womenmentioning
confidence: 99%
“…China is facing a great challenge of IHD, with a disability-adjusted of life years (DALY) rate of 2131/100,000 in 2017 (3). The total cost of IHD hospital admissions was the highest among all CVDs in 2018, reaching 111,982 million yuan (4).The major subtypes of IHD include coronary artery disease (CAD) and acute coronary syndromes (ACS) (5).…”
Section: Introductionmentioning
confidence: 99%
“…The total cost of IHD hospital admissions was the highest among all CVDs in 2018, reaching 111,982 million yuan [4]. The major subtypes of IHD include coronary artery disease (CAD) and acute coronary syndromes (ACSs) [5].…”
Section: Introductionmentioning
confidence: 99%